United States

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

  

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): October 27, 2020

 

CHINA JO-JO DRUGSTORES, INC.

(Exact name of Registrant as specified in charter)

 

Nevada   001-34711   98-0557852
(State or other jurisdiction
of Incorporation)
  (Commission File No.)   (IRS Employer
Identification No.)

 

Hai Wai Hai Tongxin Mansion Floor 6 Gong Shu District,

Hangzhou City, Zhejiang Province, People’s Republic of China, 310008

(Address of principal executive offices) (Zip Code)

 

Registrant’s telephone number, including area code: +86-571-88219579

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 
Securities registered pursuant to Section 12(b) of the Act:

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock   CJJD   NASDAQ Capital Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 

 

 

 

 

Item 5.07 Submission of Matters to a Vote of Security Holders.

 

On October 27, 2020, China Jo-Jo Drugstores, Inc. (the “Company”) held its annual meeting of shareholders for its fiscal year ended March 31, 2020. A quorum was present at the meeting as required by the Bylaws of the Company, as amended. The final voting results for each matter submitted to a vote of shareholders at the meeting are as follows. No broker non-votes were counted for any of the proposals.

 

1. A proposal to elect six directors to the Company’s board of directors to hold office until the next annual meeting and until their successors are duly elected and qualified:

 

Director’s Name   Votes For     Votes Against  
Lei Liu     20,073,588       78,169  
Li Qi     20,073,676       78,081  
Caroline Wang     19,638,512       513,244  
Jiangliang He     19,639,830       511,927  
Genghua Gu     19,636,335       525,422  
Pingfan Wu     20,070,709       81,048  

  

2. A proposal to ratify the appointment of BDO CHINA SHU LUN PAN Certified Public Accountants LLP as the Company's independent registered public accounting firm for the fiscal year ending March 31, 2021:

 

For     Against     Abstain  
  21,767,821       26,198       23,663  
   
3. A proposal to approve the Amendment No. 1 to the Company’s Amended and Restated 2010 Equity Incentive Plan:
                       

 

For     Against     Abstain  
  19,596,846       519,582       35,328  
                     

 

Pursuant to the foregoing votes, (i) Lei Liu, Li Qi, Caroline Wang, Jiangliang He, Genghua Gu and Pingfan Wu were elected to serve as the Company’s board of directors to hold office until the next annual meeting and until their successors are duly elected and qualified; (ii) BDO CHINA SHU LUN PAN Certified Public Accountants LLP was ratified as the Company’s independent registered public accounting firm for the fiscal year ending March 31, 2021; and (iii) the Amendment No. 1 to the Company’s Amended and Restated 2010 Equity Incentive Plan was approved.

 

 

1

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

  

  CHINA JO-JO DRUGSTORES, INC.
     
Date: October 29, 2020 By: /s/ Ming Zhao
  Name:  Ming Zhao
  Title: Chief Financial Officer

 

 

2

 

China Jo Jo Drugstores (NASDAQ:CJJD)
Historical Stock Chart
From Jun 2021 to Jul 2021 Click Here for more China Jo Jo Drugstores Charts.
China Jo Jo Drugstores (NASDAQ:CJJD)
Historical Stock Chart
From Jul 2020 to Jul 2021 Click Here for more China Jo Jo Drugstores Charts.